The regulatory role of IL-37 and IL-38 in CAR-T associated cytokine release syndrome in multiple myeloma
Multiple myeloma remains largely incurable despite advances in proteasome inhibitors and monoclonal antibodies. Chimeric antigen receptor (CAR)-T-cell therapy targeting B-cell maturation antigen (BCMA) has achieved deep responses in relapsed/refractory…